A dual responsive nanohydrogel system for sustained drug delivery and cartilage penetration in osteoarthritis therapyKai Zhou, Zhiyong Qian, Chen Yang et al.|Journal of Controlled Release|2025Cited by 6
985P Analysis of antidrug antibodies (ADA) to camrelizumab in CARES-310: The pivotal phase III study of camrelizumab + rivoceranib in unresectable hepatocellular carcinoma (uHCC)Ahmed O. Kaseb, Laura E. Crotty Alexander, James M. Bugni et al.|Annals of Oncology|2024Cited by 1